GlassScriptPhysician profile
William Edward Harder
NPI 1225417660
$7,485.64
in general payments reported to CMS, 2019-2025
38 companies · $1,461 in 2025
The $1,461 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $132 · 2021: $301 · 2022: $842 · 2023: $2,098 · 2024: $2,258 · 2025: $1,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,818.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,310.10 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $599.58 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $534.01 | 2019-2025 | Farxiga, Wainua, Andexxa |
| Novartis Pharmaceuticals Corporation | $489.81 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $481.46 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $456.36 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $448.80 | 2021-2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $334.12 | 2022-2025 | Amvuttra |
| Pfizer INC. | $273.85 | 2022-2025 | |
| Boston Scientific Corporation | $211.13 | 2022-2025 | Lux-Dx Insertable Cardiac Monitor, Cds - Mct/Cem Monitoring |
| Abbott Laboratories | $199.68 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Graftmaster |
| Novo Nordisk INC | $194.48 | 2024-2025 | Wegovy |
| Actelion Pharmaceuticals US, INC. | $193.13 | 2021-2025 | Opsumit, Uptravi |
| Lexicon Pharmaceuticals, INC. | $151.02 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $147.84 | 2023-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $140.06 | 2023-2024 | Impella |
| Terumo Medical Corporation | $121.67 | 2020-2024 | Angio-Seal, Tr Band |
| Amgen INC. | $114.69 | 2022-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $105.83 | 2021-2025 | Camzyos |
| Medtronic, INC. | $104.90 | 2022-2024 | Onyx Frontier, Symplicity G3 |
| Kestra Medical Technology Services, INC. | $101.95 | 2024-2025 | Assure Wcd |
| Heartflow, INC. | $96.21 | 2024 | |
| Edwards Lifesciences Corporation | $89.89 | 2022-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bayer Healthcare Pharmaceuticals INC. | $75.28 | 2024-2025 | |
| Esperion Therapeutics, INC. | $72.74 | 2022-2025 | Nexletol |
| Cordis US Corp. | $64.73 | 2024-2025 | Mynx Control |
| Tactile Systems Technology INC | $56.27 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Kiniksa Pharmaceuticals International, Plc | $55.56 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $54.50 | 2025 | Attruby |
| Amarin Pharma, INC. | $51.82 | 2021-2022 | |
| Stryker Corporation | $28.69 | 2025 | Artix Mt |
| Daiichi Sankyo INC. | $24.09 | 2023 | Injectafer |
| Mannkind Corporation | $23.38 | 2025 | |
| Impulse Dynamics (USA) INC. | $21.42 | 2023 | Optimizer |
| Siemens Medical Solutions USA, INC. | $16.69 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Vivaquant INC, Dba Rhythm Express | $14.06 | 2024 | Rhythm Express |
| Teleflex LLC | $13.64 | 2023 | Guideliner |
| Cardinal Health 200 LLC | $12.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Harder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.